NEONeoGenomics, Inc.
What is the market doing?
No clear lean: nothing decisive, though heavily shorted (+11% of shares).
Choppy, but holding above its 200-day average. Price is +34% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 9, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover. Down 15% since the previous count, up from 9.0% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How NEO is trading
NeoGenomics, Inc. is +92% over the past year while the S&P 500 is +18%: 74 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +34%
vs 200-day average · a clear uptrend
- RSI (14)
- 33
RSI (14) · neutral
- Below its 52-week high
- 18%
Below its 52-week high
Details›
- Last close2026-10-09
- $16.35
- 1 monthS&P 500 +2.7%
- −6.9%
- 1 yearS&P 500 +18%
- +92%
- 5 yearsS&P 500 +88%
- −66%
- vs 50-day average$17.30
- −5.5%
- 52-week high
- $19.90
- 52-week low
- $7.19
- Annualised volatility
- 68%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-09
- −$321K
| Year | Return |
|---|---|
| 2026 (year to date) | +39% |
| 2025 | −29% |
| 2024 | +1.9% |
| 2023 | +75% |
| 2022 | −73% |
| 2021 | −37% |
| 2020 | +84% |
| 2019 | +132% |
| 2018 | +42% |
| 2017 | +3.4% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −0.26% |
| Feb | 10 | 5 of 10 | +0.41% |
| Mar | 10 | 3 of 10 | −7.7% |
| Apr | 10 | 4 of 10 | −4.2% |
| May | 10 | 6 of 10 | +3.9% |
| Jun | 10 | 8 of 10 | +8.1% |
| Jul | 11 | 9 of 11 | +7.4% |
| Aug | 11 | 6 of 11 | +9.3% |
| Sep | 11 | 4 of 11 | −5.4% |
| Oct | 11 | 5 of 11 | +2.5% |
| Nov | 10 | 8 of 10 | +15% |
| Dec | 10 | 2 of 10 | −4.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Diagnostics & Research
Ranks #16 of 21 by RyuScore